HDAC5 (Ab-498) Antibody

What is HDAC5 and what cellular functions does it regulate?

HDAC5 is a class IIa histone deacetylase that functions as a signal-responsive repressor of gene expression. It plays critical roles in regulating cell differentiation programs and has been identified as a repressor of angiogenesis in endothelial cells . HDAC5 also regulates transcriptional programs in other tissues, including the control of liver gluconeogenesis . In cardiomyocytes, HDAC5 acts as a critical signal-responsive repressor of maladaptive cardiomyocyte hypertrophy through nuclear interactions with transcription factors, including myocyte enhancer factor-2 (MEF2) .

The repressive function of HDAC5 requires its nuclear localization, where it can interact with promoters of target genes. HDAC5 does not directly bind DNA but rather associates with promoters indirectly, likely through interactions with transcription factors .

What is the specificity of the HDAC5 (Ab-498) Antibody?

The HDAC5 (Ab-498) Antibody is a rabbit polyclonal antibody that detects endogenous levels of total HDAC5 protein. It was produced by immunizing rabbits with a synthetic peptide-KLH conjugate containing the sequence around amino acids 496-500 (T-Q-S-S-P) derived from human HDAC5/7 . The antibody has been purified by affinity-chromatography using epitope-specific peptide and shows reactivity with human, mouse, and rat species .

This antibody is suitable for Western blotting (WB) and immunohistochemistry (IHC) applications, allowing researchers to detect HDAC5 protein expression and localization in various experimental settings .

How should the HDAC5 (Ab-498) Antibody be stored and handled?

The HDAC5 (Ab-498) Antibody is supplied at a concentration of 1.0 mg/mL in phosphate-buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, containing 150 mM NaCl, 0.02% sodium azide, and 50% glycerol . For long-term preservation, it should be stored at -20°C. For short-term use, storage at 4°C is recommended .

Proper handling and storage are crucial for maintaining antibody activity and specificity. Avoid repeated freeze-thaw cycles, which can compromise antibody integrity. When working with this antibody, researchers should follow standard laboratory practices for handling proteins.

How does HDAC5 regulate angiogenesis and what experimental approaches can detect this activity?

HDAC5 functions as a negative regulator of angiogenesis through repression of angiogenic genes. Experimental evidence shows that silencing HDAC5 with siRNA increases endothelial cell migration, sprouting, and tube formation, while overexpression of HDAC5 decreases sprout formation . This indicates that HDAC5 is a repressor of angiogenesis.

To investigate HDAC5's role in angiogenesis, researchers can:

• Perform siRNA-mediated silencing of HDAC5 in endothelial cells followed by in vitro angiogenesis assays such as tube formation, migration (Boyden chamber), and sprouting assays. HDAC5 siRNA significantly enhances tube formation and capillary sprout length in these assays .

• Conduct in vivo angiogenesis experiments using Matrigel plug assays. HDAC5 siRNA-transfected endothelial cells mixed with Matrigel and implanted subcutaneously in mice show increased cell invasion, CD31⁺ structures, lectin⁺ structures, and hemoglobin content compared to controls, indicating enhanced angiogenesis .

• Perform overexpression studies using wild-type and mutant HDAC5 constructs to determine structure-function relationships. The antiangiogenic activity of HDAC5 requires nuclear localization but is independent of its deacetylase activity and MEF2 binding capability .

What are the target genes regulated by HDAC5 and how can they be identified?

HDAC5 regulates multiple genes involved in angiogenesis. Microarray expression analysis and real-time PCR validation have identified several HDAC5 target genes in endothelial cells:

• Angiogenic growth factors and receptors: FGF2, neuropilin 2, VEGFR2, TGFBR2

• Guidance molecules: Slit2

• Homeodomain transcription factors: HOXA9

• Other factors: EphB4

Methodological approaches to identify HDAC5 target genes:

• Perform transcriptome profiling (microarray or RNA-seq) comparing HDAC5 siRNA-treated cells with control cells. Analysis of HDAC5-silenced endothelial cells revealed that approximately 2.0% of analyzed genes were up-regulated and 1.1% were down-regulated (>1.5-fold vs. scrambled siRNA) .

• Validate selected targets using real-time PCR. In HDAC5 siRNA-transfected HUVECs, FGF2, Slit2, and EphB4 showed time-dependent significant up-regulation .

• Conduct chromatin immunoprecipitation (ChIP) assays to demonstrate HDAC5 binding to target gene promoters. ChIP assays with cells overexpressing HDAC5 wild-type or nuclear-localized mutant (S259/498A) show that HDAC5 binds to the promoters of FGF2 and Slit2 .

• Perform functional assays to determine the causal contribution of identified targets using neutralizing antibodies or siRNA. Antagonization of FGF2 or Slit2 reduces sprout induction in response to HDAC5 siRNA, confirming their functional relevance .

What is the significance of the phosphorylation sites in HDAC5 regulation?

HDAC5 activity and subcellular localization are regulated by phosphorylation at specific serine residues. The key phosphorylation sites include Ser259, Ser279, and Ser498:

• Ser259/Ser498: Mutation of these sites to alanine (S259/498A) creates a preferentially nuclear-localized HDAC5 that significantly inhibits endothelial cell sprouting . This suggests that phosphorylation at these sites promotes nuclear export and relieves HDAC5-mediated repression of angiogenic genes.

• In cardiomyocytes, β-adrenergic receptor (β-AR) stimulation induces HDAC5 nuclear accumulation through dephosphorylation at Ser259/279/498 . This process is protein kinase A (PKA)-dependent but requires B55α-PP2A-mediated dephosphorylation of Ser259/Ser498 .

• Experimental evidence shows that mutation of Ser259/Ser498 to Ala promotes HDAC5 nuclear accumulation and MEF2 inhibition, whereas Ser279 ablation does not have such effects and does not block isoproterenol-induced nuclear accumulation .

To study HDAC5 phosphorylation:

• Use phospho-specific antibodies in Western blotting to detect changes in phosphorylation status.

• Generate phosphorylation site mutants (S→A to prevent phosphorylation or S→D/E to mimic phosphorylation) and analyze their subcellular localization and function.

• Employ pharmacological inhibitors or siRNA knockdown of specific kinases and phosphatases to determine their roles in HDAC5 regulation.

What controls should be included when using HDAC5 (Ab-498) Antibody in Western blotting?

When using HDAC5 (Ab-498) Antibody for Western blotting, researchers should include several controls to ensure specificity and validity of results:

• Positive control: Include lysates from cells known to express HDAC5 (e.g., endothelial cells, cardiac myocytes).

• Negative control: If available, use lysates from HDAC5 knockout or knockdown cells. Alternatively, use cells with naturally low HDAC5 expression.

• Loading control: Probe for housekeeping proteins (e.g., GAPDH, β-actin) to ensure equal loading across lanes.

• Peptide competition: Pre-incubate the antibody with the immunizing peptide before adding to the membrane. This should block specific binding and eliminate the HDAC5 band.

• Molecular weight marker: HDAC5 has a molecular weight of approximately 122 kDa, so ensure you're detecting a band of the appropriate size.

If detecting phosphorylated HDAC5, consider these additional controls:

• Phosphatase treatment: Treat some lysates with phosphatase to demonstrate that the signal is phosphorylation-dependent.

• Stimulation controls: Include samples from cells treated with stimuli known to affect HDAC5 phosphorylation (e.g., β-adrenergic agonists like isoproterenol that induce dephosphorylation) .

How can HDAC5 subcellular localization be accurately assessed in experimental models?

HDAC5 shuttles between the nucleus and cytoplasm in response to various signals, making accurate assessment of its subcellular localization critical for understanding its function. Several methodological approaches can be employed:

• Fluorescence microscopy:

  • Express GFP-tagged HDAC5 in cells and conduct live cell imaging to track its localization over time. Cells can be imaged at 37°C using a confocal microscope, with images captured at regular intervals (e.g., every 2 hours) .

  • For fixed cells, perform immunofluorescence using HDAC5 (Ab-498) Antibody. Fix cells in 3% paraformaldehyde/4% sucrose in PBS for 20 minutes, wash in PBS, and permeabilize in 0.5% Nonidet P-40 in PBS .

• Subcellular fractionation and Western blotting:

  • Separate nuclear and cytoplasmic fractions using commercial kits or established protocols.

  • Perform Western blotting using HDAC5 (Ab-498) Antibody on both fractions.

  • Include proper controls for each fraction (e.g., PARP or lamin for nuclear fraction, GAPDH or tubulin for cytoplasmic fraction).

• Quantitative analysis:

  • For accurate quantification, use a 3-dimensional confocal microscopy method that objectively quantifies the whole-cell nuclear/cytoplasmic distribution of HDAC5 .

  • This approach allows for precise determination of changes in HDAC5 localization in response to stimuli such as β-adrenergic receptor activation .

How can researchers effectively study the interaction between HDAC5 and its target proteins?

HDAC5 functions through interactions with various proteins including transcription factors, phosphatases, and other regulatory proteins. To study these interactions:

• Co-immunoprecipitation (Co-IP):

  • Use HDAC5 (Ab-498) Antibody to immunoprecipitate HDAC5 and associated proteins.

  • Analyze precipitated complexes by Western blotting for suspected binding partners.

  • For example, co-IP revealed a specific interaction between HDAC5 and the PP2A targeting subunit B55α, as well as catalytic and scaffolding subunits. This interaction increased >3-fold with isoproterenol treatment in cardiomyocytes .

• Chromatin immunoprecipitation (ChIP):

  • Use ChIP to study HDAC5 binding to promoter regions of target genes.

  • In endothelial cells, ChIP assays demonstrated that nuclear-localized HDAC5 binds to the promoters of FGF2 and Slit2 .

  • Quantitative PCR can be used to measure enrichment of specific promoter regions in HDAC5 immunoprecipitates .

• Protein-protein interaction assays:

  • Yeast two-hybrid screening to identify novel HDAC5 interacting proteins.

  • GST pulldown assays to confirm direct interactions.

  • Mammalian two-hybrid assays to study interactions in a cellular context.

• Functional validation:

  • Use siRNA knockdown of interaction partners to determine their functional relevance.

  • For example, knockdown of B55α in neonatal cardiomyocytes attenuated isoproterenol-induced HDAC5 dephosphorylation, confirming its role in HDAC5 regulation .

How do different class IIa HDACs compare in their effects on cellular functions?

Class IIa HDACs (HDAC4, HDAC5, HDAC7, and HDAC9) have distinct as well as overlapping functions in regulating cellular processes. Comparative analysis reveals:

• Differential effects on angiogenesis:

  • HDAC5 is a negative regulator of angiogenesis, as silencing HDAC5 enhances endothelial cell migration, sprouting, and tube formation .

  • In contrast, silencing of HDAC7 and HDAC9 blocks angiogenesis, indicating they are required for angiogenic processes .

  • HDAC7 is essential for angiogenesis, consistent with the embryonic lethal phenotype of HDAC7-deficient mice due to vascular defects .

• Effects on transcriptional regulation:

  • All class IIa HDACs can interact with MEF2 transcription factors, but HDAC5's antiangiogenic function is independent of MEF2 binding .

  • Different class IIa HDACs may regulate distinct sets of target genes. For instance, HDAC5 specifically represses angiogenic genes like FGF2 and Slit2 .

• Behavioral effects:

  • HDAC4 has roles in circadian rhythm regulation. Table 1 from search result shows that HDAC4 mutations or knockdown affect rhythmic behavior in Drosophila, with 41.3% of HDAC4 KG09091/+ flies showing arrhythmic behavior compared to 0% in controls .

When designing experiments to compare class IIa HDACs:

• Use siRNA targeting individual HDACs to assess their specific roles

• Verify specificity of knockdown by measuring expression of other HDAC isoforms

• Employ functional assays relevant to the cellular process being studied

• Consider compensatory mechanisms among family members

What are the key methodological approaches for studying HDAC5-mediated transcriptional repression?

To investigate HDAC5's role in transcriptional repression, researchers can employ several complementary approaches:

• Gene expression analysis:

  • Conduct RNA-seq or microarray analysis comparing HDAC5-knockdown or overexpression cells with controls.

  • Use real-time PCR to validate changes in expression of specific target genes.

  • In endothelial cells, HDAC5 silencing led to upregulation of angiogenic genes including FGF2, Slit2, and EphB4 .

• Promoter binding studies:

  • Perform ChIP assays to demonstrate HDAC5 binding to target gene promoters.

  • ChIP-seq can identify genome-wide binding sites of HDAC5.

  • For individual genes, quantitative PCR can measure enrichment of specific promoter regions in HDAC5 immunoprecipitates .

• Promoter activity assays:

  • Use luciferase reporter constructs containing promoters of HDAC5 target genes.

  • Measure how HDAC5 knockdown or overexpression affects promoter activity.

  • Include mutational analysis of potential binding sites to identify critical regulatory elements.

• Histone acetylation analysis:

  • Assess the acetylation status of histones at HDAC5 target gene promoters using ChIP with antibodies against acetylated histones.

  • Compare acetylation levels between HDAC5-manipulated cells and controls.

• Functional validation:

  • Determine the causal contribution of HDAC5-regulated genes to cellular phenotypes.

  • For example, antagonization of FGF2 or Slit2 reduces sprout induction in response to HDAC5 siRNA, confirming their functional relevance in angiogenesis .

How can researchers distinguish between deacetylase-dependent and deacetylase-independent functions of HDAC5?

HDAC5 can regulate gene expression and cellular functions through both deacetylase-dependent and deacetylase-independent mechanisms. To distinguish between these functions:

• Use deacetylase-dead mutants:

  • Generate HDAC5 mutants that lack deacetylase activity but maintain other functions.

  • Compare the effects of wild-type HDAC5 with deacetylase-dead mutants on cellular phenotypes and gene expression.

  • Research has shown that the antiangiogenic activity of HDAC5 is independent of its deacetylase activity .

• HDAC inhibitor studies:

  • Use specific HDAC inhibitors targeting class IIa HDACs.

  • If inhibiting the deacetylase activity of HDAC5 does not affect a particular function, this suggests a deacetylase-independent mechanism.

  • Compare the effects of HDAC inhibitors with HDAC5 knockdown or overexpression.

• Domain deletion/mutation studies:

  • Create HDAC5 constructs with various domain deletions or mutations.

  • The repressive function of HDAC5 requires nuclear localization but is independent of MEF2 binding .

  • Test these constructs in functional assays to determine which domains are required for specific activities.

• Analysis of protein-protein interactions:

  • Identify proteins that interact with HDAC5 and determine if these interactions require deacetylase activity.

  • Some HDAC5 functions may be mediated by its role as a scaffold for other proteins, independent of its enzymatic activity.

• Assessment of acetylation status:

  • Measure histone and non-histone protein acetylation at HDAC5 target genes or proteins.

  • If HDAC5 regulates a process without affecting acetylation levels, this suggests a deacetylase-independent mechanism.